体外受精の世界市場：洞察、競合情勢、市場予測：2028年

世界の体外受精の市場規模は、2023年から2028年までの予測期間中に6.31％のCAGRで拡大すると予測されています。体外受精の需要は主に、男女ともに不妊症の症例が増加していること、妊娠の開始が遅れていること、性の健康に関する問題、体外受精技術の成功率の上昇、肥満率の増加、体外受精の高度で拡張された不妊治療、すなわち卵細胞質内精子注入法（ICSI）の導入、製品の発売と承認の増加、製品開発の革新などによって後押しされており、それによって2023年から2028年までの予測期間中に体外受精市場の全体的な成長に貢献しています。

世界中で不妊症とそのリスク因子の有病率が上昇していることから、体外受精市場全体が拡大すると考えられます。不妊症は世界中のカップルのかなりの割合を占めており、妊娠したいという願望が不妊症関連の製品やサービスに対する需要を促進しています。経済協力開発機構（OECD）2023年版が発表したデータによると、2021年の韓国、フランス、スウェーデン、スイスの合計特殊出生率（TFR）はそれぞれ0.81、1.80、1.67、1.51で、平均TFRの2.1を下回っています。

世界保健機関（WHO）の2023年の推計によると、世界の生殖年齢にある人の約6人に1人が生涯に不妊を経験します。世界中のさまざまな地域で不妊症が増加しているため、予測期間中に体外受精（IVF）の需要が増加します。

しかし、偽陽性の結果、低い保険適用範囲、新興市場における保険の不在などが、体外受精市場全体の成長を制限するとみられていまます。

当レポートでは、世界の体外受精市場について調査し、市場の概要とともに、製品別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 体外受精市場レポートのイントロダクション

第2章 体外受精市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 体外受精市場の主要な要因分析

• 体外受精市場の促進要因
• 体外受精市場の抑制要因と課題
• 体外受精市場の機会

第5章 体外受精市場におけるポーターのファイブフォース分析

第6章 体外受精市場の概要

• 製品別
• エンドユーザー別
• 地域別

第7章 体外受精市場の企業と製品プロファイル

• CooperSurgical, Inc
• Cook Medical
• FUJIFILM Holdings America Corporation
• Genea Biomedx
• Hamilton Thorne
• Merck KGaA
• SRL Diagnostic
• Nikon Instruments Inc.
• Thermo Fisher Scientific Inc.
• Vitrolife
• Sysmex Corporation
• Rocket Medical plc.
• Menicon Co. Ltd.
• LensHooke
• Promega Corporation

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: In Vitro Fertilization Market in Global (2020-2028)
• Table 3: In Vitro Fertilization Market in Global by Product (2020-2028)
• Table 4: In Vitro Fertilization Market in Global by End-User (2020-2028)
• Table 5: In Vitro Fertilization Market in Global by Geography (2020-2028)
• Table 6: In Vitro Fertilization Market in North America (2020-2028)
• Table 7: In Vitro Fertilization Market in the US (2020-2028)
• Table 8: In Vitro Fertilization Market in Canada (2020-2028)
• Table 9: In Vitro Fertilization Market in Mexico (2020-2028)
• Table 10: In Vitro Fertilization Market in Europe (2020-2028)
• Table 11: In Vitro Fertilization Market in France (2020-2028)
• Table 12: In Vitro Fertilization Market in Germany (2020-2028)
• Table 13: In Vitro Fertilization Market in the United Kingdom (2020-2028)
• Table 14: In Vitro Fertilization Market in Italy (2020-2028)
• Table 15: In Vitro Fertilization Market in Spain (2020-2028)
• Table 16: In Vitro Fertilization Market in the Rest of Europe (2020-2028)
• Table 17: In Vitro Fertilization Market in Asia-Pacific (2020-2028)
• Table 18: In Vitro Fertilization Market in China (2020-2028)
• Table 19: In Vitro Fertilization Market in Japan (2020-2028)
• Table 20: In Vitro Fertilization Market in India (2020-2028)
• Table 21: In Vitro Fertilization Market in Australia (2020-2028)
• Table 22: In Vitro Fertilization Market in South Korea (2020-2028)
• Table 23: In Vitro Fertilization Market in Rest of Asia-Pacific (2020-2028)
• Table 24: In Vitro Fertilization Market in the Rest of the World (2020-2028)
• Table 25: In Vitro Fertilization Market in the Middle East (2020-2028)
• Table 26: In Vitro Fertilization Market in Africa (2020-2028)
• Table 27: In Vitro Fertilization Market in South America (2020-2028)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: In Vitro Fertilization Market in Global (2020-2028)
• Figure 3: In Vitro Fertilization Market in Global by Product (2020-2028)
• Figure 4: In Vitro Fertilization Market in Global by End-User (2020-2028)
• Figure 5: In Vitro Fertilization Market in Global by Geography (2020-2028)
• Figure 6: In Vitro Fertilization Market in North America (2020-2028)
• Figure 7: In Vitro Fertilization Market in the US (2020-2028)
• Figure 8: In Vitro Fertilization Market in Canada (2020-2028)
• Figure 9: In Vitro Fertilization Market in Mexico (2020-2028)
• Figure 10: In Vitro Fertilization Market in Europe (2020-2028)
• Figure 11: In Vitro Fertilization Market in France (2020-2028)
• Figure 12: In Vitro Fertilization Market in Germany (2020-2028)
• Figure 13: In Vitro Fertilization Market in the United Kingdom (2020-2028)
• Figure 14: In Vitro Fertilization Market in Italy (2020-2028)
• Figure 15: In Vitro Fertilization Market in Spain (2020-2028)
• Figure 16: In Vitro Fertilization Market in the Rest of Europe (2020-2028)
• Figure 17: In Vitro Fertilization Market in Asia-Pacific (2020-2028)
• Figure 18: In Vitro Fertilization Market in China (2020-2028)
• Figure 19: In Vitro Fertilization Market in Japan (2020-2028)
• Figure 20: In Vitro Fertilization Market in India (2020-2028)
• Figure 21: In Vitro Fertilization Market in Australia (2020-2028)
• Figure 22: In Vitro Fertilization Market in South Korea (2020-2028)
• Figure 23: In Vitro Fertilization Market in Rest of Asia-Pacific (2020-2028)
• Figure 24: In Vitro Fertilization Market in the Rest of the World (2020-2028)
• Figure 25: In Vitro Fertilization Market in the Middle East (2020-2028)
• Figure 26: In Vitro Fertilization Market in Africa (2020-2028)
• Figure 27: In Vitro Fertilization Market in South America (2020-2028)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Marker Opportunities
• Figure 31: PORTER'S Five Force Analysis

In Vitro Fertilization Market By Product (Instrument [Imaging Systems, Incubators, Cryosystems, Ivf Cabinet, Sperm Separation Devices, Ovum Aspiration Pump, And Others] And Reagent), End-User (Hospitals, Fertility Clinics, And Others), and geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing cases of infertility and delay in pregnancies.

The global in vitro fertilization market is estimated to grow at a CAGR of 6.31% during the forecast period from 2023 to 2028. The demand for in vitro fertilization is primarily being boosted by the increasing cases of infertility among both men and women, delayed onset of pregnancies, issues pertaining to sexual health, rising success rate of IVF technology, the growing obesity rate, introduction of advanced and extended fertility treatment of IVF i.e. intracytoplasmic sperm injection (ICSI), increasing product launches and approvals, and innovation in product development among others, thereby contribute to the overall growth of the in vitro fertilization market during the forecast period from 2023-2028.

In Vitro Fertilization Market Dynamics:

The rising prevalence of infertility and its risk factors across the globe will increase the overall market of in vitro fertilization. Infertility affects a significant percentage of couples worldwide, and the desire to conceive has fueled the demand for fertility-related products and services. The data published by the Organization for Economic Co-operation and Development (OECD) 2023 says that in 2021 the total fertility rate (TFR) in Korea, France, Sweden, and Switzerland was 0.81, 1.80, 1.67, and 1.51 respectively which is less than average TFR of 2.1.

As per the above-mentioned source, the TFR for most of the countries in 2020 was below the average TFR with Australia having a TFR of 1.58, Canada at 1.50, China at 1.70, the United States at 1.64, the United Kingdom at 1.56, Spain 1.36, Japan 1.33, and South Korea with 0.84 TFR.

The World Health Organization (WHO) 2023 estimates suggest that approximately one in every six people of reproductive age worldwide experience infertility in their lifetime.

According to World Bank 2022, the total fertility rate (TFR) in most of the regions including North and South America to Europe and Asia-Pacific was 1.6 in 2020 which is comparatively lower than the average TFR of 2.1.

The increasing infertility among the different regions across the globe will increase the demand for in vitro fertilization (IVF) during the forecast period.

In addition, there's a rising push by the government and other groups to start several public education programs regarding reproductive health, available treatments, and the causes of infertility problems. For example, Pinnacle Fertility started the Save IVF campaign in August 2022 to raise awareness about possible new laws that could endanger family-building procedures. In honor of World IVF Day, Oasis Fertility also started the Infertility Knows No Gender campaign in July 2022. Millions of infertile couples have a glimmer of hope because of in vitro fertilization (IVF).

Furthermore, the increasing launches of IVF facilities and new technologies across the globe for providing better services are also contributing to segment growth. For instance, in August 2022, the Rejuvenating Fertility Center (RFC) launched Injection-Free IVF or Needle-Free IVF procedures. This non-conventional holistic treatment uses oral and nasal fertility drugs to stimulate the patient's ovaries during in vitro fertilization (IVF). This gently stimulates the ovaries to produce multiple higher-quality eggs. Such developments are expected to increase the demand for needleless IVF treatment.

Therefore, the above-mentioned factors will propel the in vitro fertilization market during the forecast period from 2023-2028.

However, false positive results, low coverage, or absence of insurance in the emerging market, and others may restrict the growth of the overall in vitro fertilization market.

In Vitro Fertilization Market Segment Analysis:

In Vitro Fertilization Market by Product (Instrument [Imaging Systems, Incubators, Cryosystems, IVF Cabinet, Sperm Separation Devices, Ovum Aspiration Pump, and Others] and Reagent), End-User (Hospitals, Fertility Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the in vitro fertilization market, the sperm separation devices category is expected to amass a significant revenue share in the year 2022. This can be ascribed to the advantages and applications associated with the segment.

In most assisted reproductive technologies (ART), such as in vitro fertilization (IVF) and artificial insemination, sperm separation systems are used. These systems are critical for assisted reproductive technologies (ARTs) because they provide purified samples that can be used in subsequent procedures. These systems are crucial for ARTs as they provide purified samples for further procedures.

The market is predicted to rise as a result of the growing usage of cutting-edge technologies, such as sperm syringes, in the process of choosing high-quality sperm. With a sperm syringe, a highly parallelized and quick sorting mechanism is made possible by providing the maximal contact area between 1.5 ml of the semen sample and selection events. This retrieval efficiency allows for more frequent avoidance of the more invasive intracytoplasmic sperm injection (ICSI) method by providing a sufficient volume and number of high-quality sperm for droplet-based IVF and intrauterine insemination (IUI). Additionally, compared to intracytoplasmic sperm injection, sperm syringes provide clinics with a viable alternative for implementing less invasive assisted reproductive technologies (ARTs), hence minimizing the associated clinical strain and enhancing the long-term health outcomes for ART-conceived infants.

Therefore, owing to the above-mentioned factors, the sperm separation devices category is expected to register significant growth, thereby driving the growth of the overall in vitro fertilization market during the forecast period.

North America is expected to dominate the overall In Vitro Fertilization Market:

Among all the regions, North America is estimated to account for the largest share of the In Vitro Fertilization market in the year 2022. Owing to the significance of key growth factors such as the rising prevalence of associated conditions such as polycystic ovary syndrome (PCOS), standardization of procedures, government funding for sperm and egg storage, a constant rise in the incidence of infertility in both sexes, the presence of various leading players in this region, the growing number of single women and same-sex couples, and favorable regulatory reforms, presence of key players, increasing product development activities, and others, the market for in vitro fertilization is expected to witness prosperity in the region during the forecast period 2022-2028.

As per the data provided by the Centers for Disease Control and Prevention (CDC) 2023, in the United States, among married women aged 15 to 49 years with no prior births, about 1 in 5 (19%) are unable to get pregnant after one year of trying (infertility). Also, about 1 in 4 (26%) women have difficulty getting pregnant or carrying a pregnancy to term (impaired fecundity). Also, infertility and impaired fecundity are less common among women with one or more prior births. About 6% of married women aged 15 to 49 years are unable to get pregnant after one year of trying and 14% have difficulty getting pregnant or carrying a pregnancy to term.

Canada is a low-fertility country or below the no-migration population replacement level of 2.1 children per woman. As per Statistics Canada 2022, the country's fertility rate decreased from 1.47 children per woman in 2019 to a record low of 1.40 children per woman in 2020.

The World Population Data Sheet 2022, stated that in 2022, the fertility rate in Mexico was 1.8 children per woman.

As per the OECD datasheet 2020, it was estimated that by 2050, the fertility rate in Mexico will amount to 1.72 children per woman.

Thus, from the above sources it can be concluded that the prevalence of infertility is increasing in different countries within the North American region.

The increasing adoption of various business strategies such as acquisitions, partnerships, and others by the companies increases the introduction of advanced fertility treatment centers and options, which is anticipated to propel market growth. For instance, in December 2021, Cooper Companies acquired Generate Life Sciences, a provider of donor eggs and sperm for fertility treatments, fertility cryopreservation services, and newborn stem cell storage (cord blood and cord tissue) for approximately USD 1.6 billion. With this acquisition, CooperSurgical can offer fertility clinics, Obstetrics, and Gynaecology even stronger services and products.

Thus, the above-mentioned factors are likely to propel the growth of the in vitro fertilization market in the region during the forecast period from 2023-2028.

In Vitro Fertilization Market Key Players:

Some of the key market players operating in the in vitro fertilization market include: CooperSurgical, Inc., Cook Medical, FUJIFILM Holdings America Corporation, Genea Biomedx, Hamilton Thorne, Merck KGaA, SRL Diagnostic, Nikon Instruments Inc., Thermo Fisher Scientific Inc., Vitrolife, Sysmex Corporation, Rocket Medical plc., Menicon Co. Ltd., LensHooke, Promega Corporation, and others.

Recent Developmental Activities in the In Vitro Fertilization Market:

• In May 2023, AIVF, the developer of AI-based solutions for IVF clinics, and Genea Biomedx launched an integrated system. The new integrated solution provides widespread access to individualized, improved IVF care by connecting Genea Biomedx's Geri time-lapse incubator with AIVF's innovative EMA AI platform.
• In December 2022, Kindbody launched a state-of-the-art clinic and in vitro fertilization (IVF) lab in Dallas to meet the increasing demand for world-class fertility care and comprehensive family-building benefits by patients and employers in the area.
• In March 2022, Malta, in collaboration with Pera Labs's commercialization advisors at the University City Science Center, started the research and development of an AI-powered sperm and egg selection technology for fertility treatments. Pera Labs's Malta operations are accelerated by the EUR 800,000 (USD 8,83,040) of financial support from Malta Enterprise, coupled with Pera Labs's financing.

Key Takeaways from the In Vitro Fertilization Market Report Study:

• Market size analysis for current in vitro fertilization market size (2022), and market forecast for 5 years (2023-2028)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global in vitro fertilization market.
• Various opportunities available for the other competitors in the in vitro fertilization market space.
• What are the top-performing segments in 2022? How these segments will perform in 2028?
• Which are the top-performing regions and countries in the current in vitro fertilization market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for in vitro fertilization market growth in the coming future?

Target Audience who can be benefited from this In Vitro Fertilization Market Report Study:

• In Vitro Fertilization product providers
• Research organizations and consulting companies
• In Vitro Fertilization-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in In Vitro Fertilization
• Various End-users who want to know more about the in vitro fertilization market and the latest technological developments in the in vitro fertilization market.

Frequently Asked Questions for the In Vitro Fertilization Market:

1. What is in vitro fertilization?

• In vitro fertilization is an assistive reproductive technology that involves the process of fertilization by retrieving eggs from the woman's ovaries and fertilizing them with sperm outside of the body in a laboratory environment.

2. What is the market for global in vitro fertilization?

• The global in vitro fertilization market is estimated to grow at a CAGR of 6.31% during the forecast period from 2023 to 2028.

3. What are the drivers for the global in vitro fertilization market?

• The demand for in vitro fertilization is primarily being boosted by the increasing prevalence of infertility, increasing success rate of IVF procedures, increasing awareness about infertility the introduction of advanced and extended fertility treatment of IVF, delay in pregnancies, increasing product launches and approvals, and others thereby contributing to the overall growth of the in vitro fertilization market during the forecast period from 2023-2028.

4. Who are the key players operating in the global in vitro fertilization market?

• Some of the key market players operating in the in vitro fertilization market include CooperSurgical, Inc., Cook Medical, FUJIFILM Holdings America Corporation, Genea Biomedx, Hamilton Thorne, Merck KGaA, SRL Diagnostic, Nikon Instruments Inc., Thermo Fisher Scientific Inc., Vitrolife, Sysmex Corporation, Rocket Medical plc., Menicon Co. Ltd., LensHooke, Promega Corporation, and others.

5. Which region has the highest share in the in vitro fertilization market?

• North America is expected to dominate the overall in vitro fertilization market during the forecast period from 2023-2028. Owing to factors such as increasing cases of male & female infertility, rising prevalence of associated conditions such as polycystic ovary syndrome (PCOS), standardization of procedures, government funding for sperm and egg storage, presence of various leading players in this region, the growing number of single women and same-sex couples among others, favorable regulatory reforms, among other North America in vitro fertilization market is expected to growth in coming years.

Table of Contents

1. In Vitro Fertilization Market Report Introduction

2. In Vitro Fertilization Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. In Vitro Fertilization Market Key Factors Analysis

• 4.1. In Vitro Fertilization Market Drivers
  • 4.1.1. Increasing cases of infertility among both men and women
  • 4.1.2. Delayed onset of pregnancies
  • 4.1.3. Rising success rate of IVF technology
• 4.2. In Vitro Fertilization Market Restraints and Challenges
  • 4.2.1. Complications Associated with In Vitro Fertilization
  • 4.2.2. Social stigma, ethical, and legal issues associated with in vitro fertilization
• 4.3. In Vitro Fertilization Market Opportunities
  • 4.3.1. Artificial intelligence and machine learning making their way into the world of IVF
  • 4.3.2. Increasing demand for ovarian tissue cryopreservation technology

5. In Vitro Fertilization Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. In Vitro Fertilization Market Layout

• 6.1. By Product
  • 6.1.1. Instrument
    • 6.1.1.1. Imaging systems
    • 6.1.1.2. Incubators
    • 6.1.1.3. Cryosystems
    • 6.1.1.4. IVF Cabinet
    • 6.1.1.5. Sperm Separation Devices
    • 6.1.1.6. Ovum Aspiration Pump
    • 6.1.1.7. Others
  • 6.1.2. Reagent
• 6.2. By End-User
  • 6.2.1. Hospitals
  • 6.2.2. Fertility Clinics
  • 6.2.3. Others
• 6.3. By Geography
  • 6.3.1. North America In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.1.1. United States In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.1.2. Canada In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.1.3. Mexico In Vitro Fertilization Market Size in USD million (2020-2028)
  • 6.3.2. Europe In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.2.1. France In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.2.2. Germany In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.2.3. United Kingdom In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.2.4. Italy In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.2.5. Spain In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.2.6. Rest of Europe In Vitro Fertilization Market Size in USD million (2020-2028)
  • 6.3.3. Asia-Pacific In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.3.1. China In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.3.2. Japan In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.3.3. India In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.3.4. Australia In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.3.5. South Korea In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.3.6. Rest of Asia-Pacific In Vitro Fertilization Market Size in USD million (2020-2028)
  • 6.3.4. Rest of the World (RoW) In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.4.1. Middle East In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.4.2. Africa In Vitro Fertilization Market Size in USD million (2020-2028)
    • 6.3.4.3. South America In Vitro Fertilization Market Size in USD million (2020-2028)

7. In Vitro Fertilization Market Company and Product Profiles

• 7.1. CooperSurgical, Inc.
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Cook Medical
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. FUJIFILM Holdings America Corporation
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Genea Biomedx
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Hamilton Thorne
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Merck KGaA
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. SRL Diagnostic
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Nikon Instruments Inc.
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Thermo Fisher Scientific Inc.
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Vitrolife
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Sysmex Corporation
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Rocket Medical plc.
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Menicon Co. Ltd.
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. LensHooke
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Promega Corporation
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us